Refractory Renal Pelvis and Ureter Urothelial Carcinoma
1 clinical trials · Condition
◉ Watch Refractory Renal Pelvis and Ureter Urothelial Carcinoma
| Record | Firm | Date |
|---|---|---|
| Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers (NCT07087860) | Mayo Clinic | 2025-08-01 |
Track Refractory Renal Pelvis and Ureter Urothelial Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.